Approach to diabetes in pregnancy: Clinical sciences

Last updated: February 20, 2024

Approach to diabetes in pregnancy: Clinical sciences

obs and gyn

obs and gyn

Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Anatomy of the breast
Arteries and veins of the pelvis
Nerves and lymphatics of the pelvis
Anatomy of the female urogenital triangle
Anatomy of the perineum
Anatomy of the female reproductive organs of the pelvis
Anatomy clinical correlates: Breast
Anatomy clinical correlates: Female pelvis and perineum
Development of the reproductive system
Mammary gland histology
Ovary histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the female reproductive system
Puberty and Tanner staging
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Oxytocin and prolactin
Stages of labor
Breastfeeding
Precocious puberty
Delayed puberty
Klinefelter syndrome
Turner syndrome
Androgen insensitivity syndrome
5-alpha-reductase deficiency
Kallmann syndrome
Amenorrhea
Ovarian cyst
Premature ovarian failure
Polycystic ovary syndrome
Ovarian torsion
Krukenberg tumor
Ovarian sex-cord stromal tumors
Ovarian surface epithelial tumors
Ovarian germ cell tumors
Uterine fibroid
Endometriosis
Endometritis
Endometrial hyperplasia
Endometrial cancer
Choriocarcinoma
Cervical cancer
Pelvic inflammatory disease
Urethritis
Female sexual interest and arousal disorder
Orgasmic dysfunction
Genito-pelvic pain and penetration disorder
Mastitis
Fibrocystic breast changes
Intraductal papilloma
Phyllodes tumor
Paget disease of the breast
Breast cancer
Hyperemesis gravidarum
Gestational hypertension
Preeclampsia & eclampsia
Gestational diabetes
Cervical incompetence
Placenta previa
Placenta accreta
Placental abruption
Oligohydramnios
Polyhydramnios
Potter sequence
Intrauterine growth restriction
Preterm labor
Postpartum hemorrhage
Chorioamnionitis
Congenital toxoplasmosis
Congenital cytomegalovirus (NORD)
Congenital syphilis
Neonatal conjunctivitis
Neonatal herpes simplex
Congenital rubella syndrome
Neonatal sepsis
Neonatal meningitis
Miscarriage
Gestational trophoblastic disease
Ectopic pregnancy
Fetal hydantoin syndrome
Fetal alcohol syndrome
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Amenorrhea: Pathology review
Testicular and scrotal conditions: Pathology review
Sexually transmitted infections: Warts and ulcers: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review
HIV and AIDS: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Androgens and antiandrogens
Aromatase inhibitors
Uterine stimulants and relaxants
Routine prenatal care: Clinical
Hypertensive disorders of pregnancy: Clinical
Antepartum hemorrhage: Clinical
Premature rupture of membranes: Clinical
Abnormal labor: Clinical
Vaginal versus cesarean delivery: Clinical
Postpartum hemorrhage: Clinical
Gestational trophoblastic disease: Clinical
Abdominal pain: Clinical
Amenorrhea: Clinical
Contraception: Clinical
Virilization: Clinical
Infertility: Clinical
Vulvovaginitis: Clinical
Sexually transmitted infections: Clinical
Abnormal uterine bleeding: Clinical
Ovarian cysts, cancer, and other adnexal masses: Clinical
Endometrial hyperplasia and cancer: Clinical
Cervical cancer: Clinical
Vaginal cancer: Clinical
Vulvar cancer: Clinical
Urinary incontinence: Pathology review
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Induction of labor: Clinical sciences
Pain management during labor: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Ectopic pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Anemia in pregnancy: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Asthma in pregnancy: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Breast abscess: Clinical sciences
Mastitis: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Uterine atony: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Emergency contraception: Clinical sciences
Permanent contraception (sterilization): Clinical sciences
Reversible contraception: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Bacterial vaginosis: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Vaginal trichomoniasis: Clinical sciences
Vulvovaginal candidiasis: Clinical sciences
Approach to dysuria: Clinical sciences
Hepatitis B: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Adnexal torsion: Clinical sciences
Adenomyosis: Clinical sciences
Uterine leiomyoma: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Polycystic ovary syndrome (PCOS): Clinical sciences
Approach to postmenopausal bleeding: Clinical sciences
Primary dysmenorrhea: Clinical sciences
Approach to adnexal masses: Clinical sciences
Development of the fetal membranes
Development of the placenta
Development of the umbilical cord
Fetal circulation
Development of twins
Mood disorders: Pathology review
Urinary tract infections: Pathology review
Newborn management: Clinical
Mood disorders: Clinical
Perinatal infections: Clinical
Urinary tract infections: Clinical
Breast cancer: Clinical
Precocious and delayed puberty: Clinical
Congenital adrenal hyperplasia: Clinical

Decision-Making Tree

Transcript

Watch video only

Diabetes is one of the most common medical complications in pregnancy. Patients with diabetes in pregnancy are more likely to develop preeclampsia and undergo cesarean delivery. Additionally, higher glucose levels cross the placenta, resulting in an increased glucose supply to the fetus. The fetal pancreas responds by producing more insulin to handle the excess glucose. Fetal hyperinsulinemia promotes increased fat accumulation, particularly in the shoulders and chest, that can cause macrosomia; shoulder dystocia; and birth trauma.

Moreover, once the umbilical cord is clamped after delivery, the maternal glucose supply is interrupted, which can lead to neonatal hypoglycemia. Most cases of diabetes in pregnancy are gestational diabetes mellitus, or GDM, which is hyperglycemia that develops during pregnancy. However, many patients don’t receive diabetes screening before pregnancy, so it can be challenging to differentiate between GDM and previously existing, or pregestational, type 1 or type 2 diabetes.

The first step in evaluating a patient who presents for diabetes screening in pregnancy is to obtain a focused history and physical exam, ideally at the initiation of prenatal care. First, you want to assess whether a patient has a previous diagnosis of either type 1 or type 2 diabetes. If they do, that’s pregestational diabetes mellitus. This is an important distinction to make, because patients with pregestational diabetes are more likely to have significant maternal and fetal complications during pregnancy, and usually require additional monitoring.

On the flip side, if your patient has no previous diagnosis of type 1 or type 2 diabetes, your next step is to assess whether they’re at high risk for GDM. A patient who is at high risk will have an elevated BMI of at least 25, or at least 23 in patients of Asian descent; plus one or more additional risk factors. These additional risk factors in history include GDM in a previous pregnancy; a first-degree relative with diabetes; previous delivery of an infant weighing at least 4,000 grams or about 9 pounds; or a personal history of polycystic ovarian syndrome or cardiovascular disease.

Some additional risk factors can be discovered on physical examination, including hypertension, or prepregnancy morbid obesity with a BMI greater than 40. Finally, additional risk factors related to labs include a hemoglobin A1c of 5.7 % or greater, and certain abnormal lipid values, like an HDL lower than 35 mg/dL and triglycerides higher than 250 mg/dL.

All pregnant patients should be screened for GDM - it’s just a matter of when, which is based on assessment of risk factors. First, let’s talk about patients who are at “average risk” for GDM; meaning they have no additional risk factors for GDM. Average risk patients are screened at 24 to 28 weeks of gestation with a 50-gram, one-hour oral glucose tolerance test. A normal test result indicates that the patient does not have gestational diabetes and can proceed with routine prenatal care.

Here’s a clinical pearl! The cut-off value for a normal one-hour glucose test varies between 130 and 140 mg/dL because there isn’t enough evidence to determine the ideal threshold to screen for gestational diabetes. Each clinical site or institution should decide which cut-off to use for screening and remain consistent throughout their practice.

Alright, whichever screening cut-off is used, if the one-hour glucose test for an average-risk patient is elevated, the patient should then undergo a 100-gram, three-hour oral glucose tolerance test. This test includes a fasting glucose measurement as well as additional measurements at 1, 2, and 3 hours after consuming the glucose load.

Here’s a high-yield fact! A commonly used set of diagnostic thresholds for the three-hour glucose test is the Carpenter and Coustan criteria, which include normal glucose values of fasting below 95, a one-hour result below 180, a two-hour result below 155, and a three-hour result below 140. Another acceptable approach would be to use glucose values established by the National Diabetes Data Group, which are fasting less than 105, a one-hour less than 190, a two-hour less than 165, and a three-hour less than 145.

Okay, back to our patient. The three-hour test is considered normal if no more than one of the four values is elevated. A normal 3-hour test result at 24 to 28 weeks means that your patient does not have gestational diabetes and can resume routine prenatal care.

Sources

  1. "ACOG Practice Bulletin No. 201: Pregestational diabetes mellitus" Obstet Gynecol (2018)
  2. "ACOG Practice Bulletin No. 190: Gestational diabetes mellitus" Obstet Gynecol (2018)
  3. "Lifestyle interventions for the treatment of women with gestational diabetes" Cochrane Database Syst Rev (2017)